BNTX vs WST
BioNTech SE vs West Pharmaceutical Services — AI-powered side-by-side comparison
VS
WST
West Pharmaceutical Services
74
Buy
| Metric | BNTX | WST |
|---|
| AI Score |
66
|
74
|
| Price |
$92.76
|
$351.74
|
| P/E Ratio |
-11.76×
|
44.65×
|
| ROE |
-5.7%
|
15.5%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
68.9%
|
36.8%
|
| Debt / Equity |
0.02×
|
0.10×
|
| Dividend Yield |
0.0%
|
0.3%
|
| RSI (14) |
54.0
|
58.0
|
| Beta |
1.278
|
1.138
|
| Expected Upside |
—
|
—
|
AI Committee View
Current Innellis committee reasoning for BNTX versus WST.
WST leads by 8 points.
WST scores 74/100 (Buy) versus BNTX at 66/100 (Buy).
BNTX Committee View
50% agreement
4 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- MACD histogram positive -- bullish momentum — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
- Market regime is bullish (Bull market -- normal position sizing) — Macro
WST Committee View
100% agreement
5 analysts
The primary driver is 5 consecutive earnings beats -- consistent execution. The main limiting factor is 2 existing position pair(s) are highly correlated already. The committee is constructive but not yet at full conviction.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical